Keywords: cambridge, antibody, technology, abandons, profitability, target, uk

Cambridge Antibody Technology abandons 2008 profitability target

Article | 23 May 2005

UK biopharmaceutical firm Cambridge Antibody Technology says that it does not now believe its previously-noted goal of achieving profitability by 2008 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Astra Zeneca

AstraZeneca

Abbott

Abbott Laboratories

Genzyme

Go to company listing

Related Drugs

adalimumab

Humira

Go to drug listing